UMEM Educational Pearls

Title: Blood Clots and Plane Travel- Are You at Risk?

Category: International EM

Keywords: deep venous thrombosis, plane travel, blood clots (PubMed Search)

Posted: 9/16/2014 by Jon Mark Hirshon, PhD, MPH, MD (Updated: 9/17/2014)
Click here to contact Jon Mark Hirshon, PhD, MPH, MD

While sitting on an international flight, ever wonder what your risks are for a blood clot?

 

General Background:

It is estimated that the risk for a deep venous thrombosis (DVT) is 3-12% on a long-haul flight. However, the real incidence is difficult to evaluate, due in part to the lack of consensus about 1) diagnostic tests, and 2) the appropriate time frame to relate a venous thromboembolic event (VTE) to travel.

 

Risks Factors for VTEs on long-haul flights:

  • General:
    • stasis: prolonged sitting & crowded conditions
    • relative hypoxia
    • dehydration

 

  • Patient specific:
    • Age >40
    • Female gender
    • Use of estrogen-containing contraceptives/hormone replacement therapy
    • Obesity
    • Varicose veins in the legs
    • Family/personal history of prior VTEs
    • Active cancer/recent cancer treatment

 

Bottom Line:

  • Even healthy individuals are at risk on long-haul (>8 hour) flights.
  • The risk increases the longer the flight
  • Current data does not appear to show a risk difference between economy and business class.
  • Avoid dehydration and immobility
    • Exercise your legs/calf muscles
    • Drink plenty of fluid

Show References



Infectious Risks Associated with TTM

  • Targeted temperature management (TTM) is commonly used in the care of patients resuscitated from cardiac arrest.
  • Despite improving neurologic outcomes, TTM can increase the risk of infection, bleeding, coagulopathy, arrhythmias, and electrolyte derangements.
  • Infectious complications of TTM are associated with increases in ICU length of stay, along with increases in the duration of mechanical ventilation.
  • Pneumonia and bacteremia are the two most common infectious complications of TTM, with S.aureus the most common single pathogen isolated in cases of infection.
  • Since TTM may suppress normal signs of infection, it is important to be vigilant for these two infectious complications.
  • At present, evidence does not support prophylactic antibiotics for all patients receiving TTM.

Show References



Question

Football player complains of sudden foot pain after begin tackled. What’s the diagnosis? 

Show Answer

Show References



Optimal Revascularization in Complex Coronary Artery Disease

- A multicenter trial 4,566 patients with NSTEMI, unstable angina, and multi-vessel coronary artery disease were enrolled comparing outcomes of cardiac stenting versus coronary artery bypass.

- Cardiac stenting was associated with improved outcomes and lower mortality in the following subgroups: age >65 years, women, unstable angina, TIMI score >4, and 2 vessel disease.

- Despite high clinical risk patients who underwent cardiac stenting compared to surgical revascularization did better in this prospective registry. 

Show References



Title: Back Pain

Category: Orthopedics

Keywords: back pain, x-ray (PubMed Search)

Posted: 9/13/2014 by Brian Corwell, MD (Updated: 11/25/2024)
Click here to contact Brian Corwell, MD

Back pain accounts for more than 2.6 million visits

30% of ED patients receive X-rays as part of their evaluation

Imaging can be avoided in a majority of these patients by focusing on high risk (red flags)  findings in the history and physical exam.

Patients who can identify a an acute inciting event without direct trauma likely have a MSK source of pain.

Imaging rarely alters management

Attempt to avoid imaging in patients with nonspecific lower back pain of less than 6 weeks duration, with a normal neurologic exam and without high risk findings (fever, cancer, IVDA, bowel or bladder incontinence, age greater than 70, saddle anesthesia, etc)

Patients with radiculopathy (sciatica) and are otherwise similar to the above also do not require emergent imaging



Title: Enterovirus D68

Category: Pediatrics

Posted: 9/12/2014 by Rose Chasm, MD (Updated: 11/25/2024)
Click here to contact Rose Chasm, MD

  • The human enterovirus D68 is a rare virus closely related to the rhinovirus which causes the common cold.  However, there have been recent outbreaks throughout the midwest and the areas are rapidly expanding.
  • Mild symptom onset of rhinorrhea and cough rapidly progress to hypoxia and respiratory distress.
  • Key features are the rapid progression, presence of wheezing even without a history of reactive airway disease, and typically an absence of consolidation on chest XR.
  • Children under 5 years and those with asthma are at the greatest risk for respiratory failure.
  • There are a limited number of labs in the US which test specifically for EV-D68. At UMMC, the Luminex respiratory virus panel can be ordered using the kit form which includes a flocked swab and viral transport media.  Unfortunately, the panel does not differentiate between the closely related enterovirus and rhinovirus. 
  • There is no definitive cure, rather only supportive care and low-threshold for admission/observation for high risk patients.

Show References



Title: A Simpler Dosing Scheme for Digoxin-Specific Antibody Fragments

Category: Toxicology

Keywords: digoxin, digoxin-specific antibody fragments, digoxin-Fab (PubMed Search)

Posted: 9/9/2014 by Bryan Hayes, PharmD (Updated: 9/11/2014)
Click here to contact Bryan Hayes, PharmD

Digoxin-specific antibody fragments (Fab) are safe and indicated in all patients with life-threatening dysrhythmias and an elevated digoxin concentration. However, full neutralizing doses of digoxin-Fab are expensive and may not be required (not to mention cumbersome to calculate).

Based on pharmacokinetic modeling and published data, a new review suggests a simpler, more stream-lined dosing scheme as follows:

  • In imminent cardiac arrest, it may be justified to give a full neutralizing dose of digoxin-Fab.

  • In acute poisoning, a bolus of 80 mg (2 vials), repeat if necessary, titrated against clinical effect, is likely to achieve equivalent benefits with much lower total doses.

  • With chronic poisoning, it may be simplest to give 40 mg (1 vial) at a time and repeat after 60 min if there is no response.

Show References



Why is everyone obsessed about blood pressure management in stroke?

Greater than 60% of patients with stroke have elevated blood pressure, and 15% have a systolic blood pressure (SBP) greater than184 mmHg. That is more common in hemorrhagic stroke than ischemic stroke. 

Whether it's an acute hypertensive response or a premorbid uncontrolled hypertension, it is likely to negatively affect the clinical course and neurological outcome. 

Below is a suumary of the current guidelines for blood pressure management of stroke subtypes; for a more detailed summary of the guidelines, refer to the original article (below)

Ischemic stroke:

Lytic patients have a target SBP of <185mmHg, whereas nonlytic patients have a higher SBP target of <220mmHg

Hemorrhagic Stroke:

Non-aneurysmal hemorrhage patients with a SBP >180mmHg have a target SBP of <160 mmHg, whereas if their SBP was 150-220 mmHg then lowering it to 140 mmHg is safe. Patients with aneurysmal hemorrhage have a target SBP of <160mmHg

Show References



 

Goal-Directed Resuscitation During Cardiac Arrest

Focusing on high-quality CPR is by far one of the most effective methods to ensure your arrested patient has the best chance to survive.  However, emerging evidence suggests that there are additional goals that we should try and accomplish during our resuscitation.

 As we continue to move toward goal-directed resuscitation strategies, optimizing coronary perfusion pressure (CPP) may be our next target in “personalizing” the care we provide to those in cardiac arrest.

A recent AHA consensus statement recommended the following physiologic goals during cardiac arrest care:

  • CPP > 20 mmHg: Estimated by diastolic BP [DBP] – [CVP] using an arterial line & central line.
  • DBP > 25 mmHg: When an a-line is present without an appropriate CVC.
  • EtCO2 > 20 mmHg: When an a-line & CVC are not present.

Each of these variables can give the provider valuable feedback about how their patient is responding to their resuscitation.  Some argue that the DBP target should be much higher (>35 mmHg), with the caveat that pharmacologic optimization can only occur once high quality CPR is confirmed.  The goal should always be to minimize the use of epinephrine whenever possible!

Bottom Line:  During your next cardiac arrest resus, consider using a goal-directed strategy by monitoring the patient’s CPP, DBP, & EtCO2 to determine the effectiveness of your resuscitation.

 

 

Suggested Reading

  1. Meaney PA, Bobrow BJ, Mancini ME, et al. Cardiopulmonary resuscitation quality: [corrected] improving cardiac resuscitation outcomes both inside and outside the hospital: a consensus statement from the American Heart Association. Circulation. 2013;128(4):417-35.
  2. Sutton RM, Friess SH, Maltese MR, et al. Hemodynamic-directed cardiopulmonary resuscitation during in-hospital cardiac arrest. Resuscitation. 2014;85(8):983-6.

Follow me on Twitter @JohnGreenwoodMD



Question

CXR shown below, what's the diagnosis? ...and name 3 differential diagnoses.

 

 

Show Answer

Show References



PARADIGM Shift in Heart Failure

- Angiotensin-converting enzymes inhibitors (ACE-I) are cornerstone for treatment of heart failure (HF) given the multiple trials which have shown their positive risk reduction in cardiovascular death.

- Studies looking at the effect of angiotensin-receptor blockers (ARBs) on mortality have been inconsistent; thus ARB's have been recommended as 2nd-line for those who have unacceptable side effects to ACE-I.

- A recent double-blinded RCT (PARADIGM-HF)  ~8400 patients with class II-IV HF w/ ejection fraction <40% were treated with enalapril (standard therapy) versus novel therapy with neprilysin (neutral endopeptidase) inhibitor combined with an ARB.

- Primary outcomes were death from cardiovascular causes and hospitalization for HF; The RCT was ceased early (~27 months) because of an overwhelming benefit with the new agent.

- At study closure death occurred 26.5% in the standard group versus 21.8% in the novel group. The risk of HF hospitalization was decreased 21% with novel therapy.

- In early studies the use of a neprilysin inhibitor combined with an ARB has shown superior effects to current standard therapy (ACE-I), however long-term effects of this novel therapy are yet to be determined. 

Show References



Title: Pre-Exposure Prophylaxis (PrEP) for Preventing HIV Infection

Category: Pharmacology & Therapeutics

Keywords: HIV, Pre-Exposure Prophylaxis, PrEP (PubMed Search)

Posted: 8/30/2014 by Bryan Hayes, PharmD (Updated: 9/6/2014)
Click here to contact Bryan Hayes, PharmD

In May 2014, the U.S. Public Health Service released the first comprehensive clinical practice guidelines for PrEP.

Pre-Exposure Prophylaxis (PrEP) has been shown to decrease the risk of HIV infection in people who are at high risk by up to 92%, if taken consistently.

How this applies to the ED patient:

  • You may start seeing more patients on only one HIV medication. The PrEP recommendation is once daily emtricitabine/tenofovir (Truvada) 200/300 mg. 
  • This is not a therapy that should generally be initiated in the ED as close outpatient monitioring and follow up is essential.

For more information, the CDC has a comprehensive website dedicated to PrEP.

Show References



Title: "Sudden Sniffing Death"

Category: Toxicology

Keywords: Halogenated hydrocarbons, cardiac sensitization (PubMed Search)

Posted: 9/4/2014 by Kishan Kapadia, DO (Updated: 11/25/2024)
Click here to contact Kishan Kapadia, DO

Dysrhythmia-induced sudden death, termed "sudden sniffing death syndrome," is well described phenomena due to inhalant (chlorinated and aromatic hydrocarbon) abuse. 

Common inhalants include:

Chlorinated hydrocarbons: Degreasers, spot removers, dry-cleaning agents

Fluorocarbons: Freon gas, deodarants

Toluene: Paint thinners, spray paint, airplane glue

Butane: Lighter fluid, fuel

Acetone: Nail polish remover

The common theory behind the syndrome is cardiac sensitization that increases susceptibility of the heart to systemic catecholamines (epinephrine, norepinephrine, etc).  Usually, it occurs after an episode of exertion in that any excess catecholamine exposure causes irritability of the myocardium, resulting in dysrhythmias (V. fib, V. tach) and cardiac arrest. 

If acute dysrhythmias is due to myocardial sensitization, sympathomimectis should be avoided.  Beta-adrenergic antagonist can be used for the catecholamine-sensitized heart.

 



Hyperthermia can be defined as a core body temperature > 38.5ºC. In contrast to fever, the body’s temperature rises uncontrollably and the body is not able to dissipate the heat. There can be many causes of hyperthermia, including from environmental exposure. 

 

There are two main environmental heat illnesses, heat exhaustion and heat stroke.

 

Heat exhaustion:

  • Vague malaise, fatigue, headache
  • Core temperature may be normal or elevated (below 40ºC)  
  • May have tachycardia, orthostatic hypotension, clinical dehydration
  • Liver function tests (transaminases) may be normal or elevated
  • IMPORTANT- there is no altered mental status (i.e.: no coma or seizures)

 

Heat stroke

  • Usually tachycardia, orthostatic hypotension, clinical dehydration
  • May have hot, dry skin, but not always
  • Liver function tests (transaminases) are markedly elevated
  • May have rhabdomyolysis and renal failure
  • IMPORTANT- Signs of altered mental status (i.e.: coma, seizure, delirium)
  • Mortality may be up to 33%

 

Bottom line:

  • Heat stroke is a life threatening emergency.
    • Early recognition and rapid appropriate therapy can save a life
  • The most effective cooling is evaporative cooling along with ice packs

Show References



Vasopressors are used in shock-states to increase mean arterial pressure (MAP) and improve distal tissue perfusion. Additionally, some agents have effects on the heart to augment cardiac output.

Receptors that vasopressors work on include: 

  • Alpha-1: increase arterial tone (increases MAP) and venous tone to reduce venous pooling and augment cardiac preload 
  • Beta-1: increase inotropy and chronotropy on heart muscle; also increases arterial tone
  • Beta-2 and Dopamine: cause vasodilation but may actually be beneficial because this increases perfusion to cardiac, renal, and GI tissues.
  • V1: arterial vasoconstriction to increase MAP
  • The chart below is a summary; please note that quoted receptor effects vary depending on the source reviewed

Norepinephrine (NE): excellent vasopressor for most types of shock and recommended as a first-line agent in the Surviving Sepsis Guidelines.

  • Works on alpha-1, beta-1, and beta-2 receptors. 
  • Initial dosing 0.05 mcg/kg/min with a maximum dose often cited as 0.5 mcg/kg/min (though there is technically no maximum dose).

Epinephrine (a.k.a. Adrenaline): in several countries the first-line agent for shock (including sepsis).

  • Works similarly to NE on alpha-1, beta-1 and beta-2; it is a more potent inotrope than NE.
  • One downside is the production of lactic acid, which can sometimes lead to confusion when following serial lactates during resuscitation. 

 

Show References



Question

You are scaning the liver with ultrasound and you see this. What's the diagnosis?

 

 

Show Answer

Show References



Title: Sick Sinus Syndrome

Category: Cardiology

Keywords: Sick Sinus Syndrome (PubMed Search)

Posted: 8/31/2014 by Semhar Tewelde, MD
Click here to contact Semhar Tewelde, MD

Sick Sinus Syndrome

- Sick sinus syndrome (SSS) is a cardiac conduction disorder characterized by symptomatic dysfunction of the sinoatrial (SA) node.

- SSS usually manifests as sinus bradycardia, sinus arrest, or sinoatrial block, and is sometimes accompanied by supraventricular tachydysrhythmias.

- Symptoms of SSS include: syncope, dizziness, palpitations, exertional dyspnea, fatigability from chronotropic incompetence, heart failure, and angina.

- Clinically significant SSS typically requires pacemaker implantation. Approximately 30% to 50% of pacemaker implantation in the United States list SSS as the primary indication.

- 2 large, prospective cohorts with an average follow-up of 17 years, observed the incidence of SSS increases with age, does not differ between men and women, and is lower among blacks than whites.

- Risk factors for SSS included greater BMI & height, elevated NT-proBNP level & cystatin C level, longer QRS interval, lower heart rate, hypertension, and right bundle branch block.

Show References



Title: Radiology Ankle Fracture Pearls

Category: Orthopedics

Keywords: radiology, ankle, fracture (PubMed Search)

Posted: 8/30/2014 by Michael Bond, MD
Click here to contact Michael Bond, MD

Some radiology pearls concerning ankle pain and fractures courtesy of David Bostick and Michael Abraham

Maisonneuve fracture – fracture of the medial malleolus with disruption of the tibiofibular syndesmosis with associated fracture of the proximal fibular shaft (http://radiopaedia.org/articles/maisonneuve-fracture)

When to look for high fibular fracture

  • Isolated fracture of medial malleolus
  • Isolated fracture of malleolus tertius without fracture on the lateral side
  • Any painful swelling or hematoma on medial side without a fracture on x-ray

Always look for avulsion fracture of 5th metatarsal styloid in patients with ankle pain and
no obvious fractures

Dans-Weber Classification – for lateral malleolar fractures (http://radiopaedia.org/articles/ankle-fracture-classification-weber)

  • Type A – fracture below ankle joint
  • Type B – at level of joint with tibifibular joint intact
  • Type C – fracture above joint with tears syndesmotic joint


Title: Traumatic Intracranial Hypertension - What to do?

Category: Neurology

Keywords: basics, trauma, critical care (PubMed Search)

Posted: 8/28/2014 by Danya Khoujah, MBBS (Updated: 11/25/2024)
Click here to contact Danya Khoujah, MBBS

Elevated intracranial pressure (ICP), defined as >20mmHg, is frequently encountered in patients with severe traumatic brain injury (TBI). A step-wise approach would include:

1.     Analgesia and sedation: frequently forgotten.

2.     Hyperosmolar agents: both hypertonic saline and mannitol can be used. Neither is superior.

3.     Induced arterial blood hypocarbia using hyperventilation (must monitor for cerebral ischemia)

4.     Barbiturates (last resort due to side effects)

5.     Surgical:

a.     CSF drain

b.     Decompressive craniectomy: benefits challenged by the DECRA study

 

Stocchetti N, Maas AIR. Traumatic Intracranial Hypertension. N Engl J Med 2014; 370:2121-30. 



Title: Enteral Nutrition in Critical Care

Category: Critical Care

Keywords: immunonutrition, enteral feeding (PubMed Search)

Posted: 8/26/2014 by Feras Khan, MD (Updated: 11/25/2024)
Click here to contact Feras Khan, MD

Background

  • Artificial nutrition is a staple of critical care
  • Patients who are unable to eat, require enteral nutrition (preferred over parental nutrition)
  • There are some formulas that are called "immunonutrition" which try to alter the inflammatory response seen in critical illness
  • They may contain omega-3 fatty acids and essential amino acids such as arginine or glutamine, and anti-oxidants.

Data

  • A recent trial (MetaPlus) was designed to see if immunonutrition could decrease the development of infections in the critically ill
  • Compared to regular high protein formulas, there was no difference in mortality, duration of ventilation, or hospital length of stay

What to do

  • Immuno-nutrition formulas cannot be routinely recommended
  • Use regular high protein formulas
  • Start within 48 hours of identifying a need

 

Show References